Cannabis -vs- Hyptertension
https://www.ncbi.nlm.nih.gov/pubmed/15451779: We conclude that endocannabinoids tonically suppress cardiac contractility in hypertension and that enhancing the CB1-mediated cardiodepressor and vasodilator effects of endogenous anandamide by blocking its hydrolysis can normalize blood pressure. Targeting the endocannabinoid system offers novel therapeutic strategies in the treatment of hypertension.
http://www.ncbi.nlm.nih.gov/pubmed/17890433: In animals, CBD reduced infarct size and reduced inflammation follow a heart attack. Cannabidiol, a nonpsychoactive cannabis constituent, protects against myocardial ischemic reperfusion injury.
http://www.ncbi.nlm.nih.gov/pubmed/19900555: CBD reduced acute and apoptotic brain damage when administered shortly after an ischemic brain event in mice. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.
http://www.ncbi.nlm.nih.gov/pubmed/25492113: Cannabinoids administered to humans shortly after a stroke reduced infarct volume and improved brain functional outcome. Cannabinoids in experimental stroke: a systematic review and meta-analysis.